(Total Views: 451)
Posted On: 04/29/2020 12:15:18 PM
Post# of 716
GILD's Remdesivir and Capricor's experimental drug both seem to have good results.
Remdesivir seems to help people who are moderately ill avoid getting sicker, so they stay out of the ICU.
CAPR's therapy addresses cytokine storm. They let 6 critically ill (terminal) patients on ventilators try it as a last resort, under Compassionate Use program. All 6 are still alive, 4 are off ventilator and out of ICU, 2 still on ventilator but improving.
Remdesivir seems to help people who are moderately ill avoid getting sicker, so they stay out of the ICU.
CAPR's therapy addresses cytokine storm. They let 6 critically ill (terminal) patients on ventilators try it as a last resort, under Compassionate Use program. All 6 are still alive, 4 are off ventilator and out of ICU, 2 still on ventilator but improving.
(1)
(0)
